Insider Shareholders with Direct Ownership of Pfizer Inc (PFE)
This section provides a comprehensive overview of the insiders with direct ownership of Pfizer Inc (PFE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
PFIZER INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Ian C Read
Executive Chairman |
1,447,528 | 1,637,097 | 1,639,280 $43.8 Million | 7 |
Mar 04, 2019
Reduced 0.22%
|
|
Frank A Damelio
Executive Vice President |
1,424,852 | 1,356,786 | 555,941 $14.9 Million | 18 |
Feb 26, 2022
Reduced 9.65%
|
|
Freda C Lewis Hall
Executive Vice President |
217,016 | 142,347 | 375,244 $10 Million | 4 |
Feb 27, 2019
Reduced 11.82%
|
|
Albert Bourla
Chairman & CEO |
1,008,531 | 757,322 | 327,739 $8.76 Million | 21 |
Feb 23, 2024
Reduced 23.94%
|
|
Mikael Dolsten
President R&D |
1,007,923 | 801,603 | 321,729 $8.6 Million | 26 |
Feb 28, 2024
Reduced 6.25%
|
|
John D Young
Group President |
878,076 | 844,855 | 312,704 $8.36 Million | 18 |
Nov 11, 2021
Reduced 13.25%
|
|
Sally Susman
Executive Vice President |
925,152 | 919,016 | 161,611 $4.32 Million | 28 |
Feb 23, 2024
Reduced 24.2%
|
|
Christoffel Boshoff
Executive Vice President |
71,451 | 19,661 | 156,007 $4.17 Million | 8 |
Feb 28, 2024
Reduced 2.59%
|
|
Douglas M Lankler
Executive Vice President |
872,619 | 810,529 | 146,918 $3.93 Million | 26 |
Feb 23, 2024
Reduced 34.5%
|
|
Loretta V Cangialosi
Sr. Vice President, Controller |
123,466 | 113,148 | 122,075 $3.26 Million | 13 |
Feb 28, 2020
Reduced 10.4%
|
|
William Pao
Executive Vice President |
115,897 | 22,095 | 97,765 $2.61 Million | 2 |
Mar 31, 2023
Reduced 18.43%
|
|
Rady A Johnson
Executive Vice President |
352,358 | 298,383 | 97,153 $2.6 Million | 26 |
Feb 23, 2024
Reduced 19.67%
|
|
Alexander R Mackenzie
Executive Vice President |
194,854 | 235,929 | 87,280 $2.33 Million | 17 |
Dec 02, 2021
Reduced 32.15%
|
|
Michael Mc Dermott
Executive Vice President |
67,189 | 62,051 | 75,463 $2.02 Million | 14 |
Feb 26, 2024
Reduced 7.44%
|
|
Alexandre De Germay
Executive Vice President |
74,377 | 0 | 74,377 $1.99 Million | 1 |
Feb 27, 2024
Added 50.0%
|
|
Laurie J Olson
Executive Vice President |
0 | 29,214 | 72,672 $1.94 Million | 2 |
Aug 13, 2018
Reduced 12.32%
|
|
William R Carapezzi Jr
Executive Vice President |
95,617 | 104,633 | 38,146 $1.02 Million | 11 |
May 12, 2022
Reduced 46.31%
|
|
David M Denton
Chief Financial Officer & EVP |
61,275 | 28,330 | 37,919 $1.01 Million | 3 |
May 31, 2024
Reduced 24.2%
|
|
Michael Goettler
Group President |
102,132 | 97,030 | 36,812 $984,352 | 11 |
Feb 28, 2020
Reduced 24.28%
|
|
Lidia Fonseca
Executive Vice President |
47,510 | 19,472 | 34,717 $928,332 | 4 |
Jan 31, 2022
Reduced 16.14%
|
|
Angela Hwang
President, Global Biopharma |
176,917 | 160,702 | 29,778 $796,263 | 19 |
Feb 25, 2023
Reduced 23.24%
|
|
Aamir Malik
Executive Vice President |
43,412 | 20,195 | 29,548 $790,113 | 2 |
Aug 31, 2024
Reduced 40.6%
|
|
Payal Sahni
Executive Vice President |
59,523 | 49,609 | 24,385 $652,054 | 14 |
Feb 23, 2024
Reduced 27.64%
|
|
Scott Gottlieb
Director |
10,000 | 0 | 10,000 $267,400 | 6 |
Oct 30, 2024
Added 9.09%
|
|
Jennifer B. Damico
SVP & Controller |
89,940 | 95,323 | 8,582 $229,482 | 32 |
Aug 13, 2024
Reduced 37.52%
|
|
Ronald E Blaylock
Director |
13,000 | 4,750 | 8,250 $220,605 | 2 |
Jun 16, 2021
Reduced 36.54%
|
|
Dawn Rogers
Executive Vice President |
76,451 | 85,281 | 4,823 $128,967 | 13 |
Apr 29, 2020
Reduced 72.94%
|
|
Kirsten Lund Jurgensen
Executive Vice President |
0 | 20,942 | 4,643 $124,153 | 1 |
Aug 01, 2018
Reduced 77.0%
|
|
W Don Cornwell
Director |
5,223 | 5,223 | 0 $0 | 2 |
Jun 04, 2018
Reduced 100.0%
|